Abstract
The Brugada syndrome (BrS) is a potentially lethal, inheritable arrhythmia syndrome affecting about 5 in 10,000 people worldwide. This cardiac disorder, triggered by mutations in SCN5A gene (encoding for cardiac sodium channels), results in changes in the onset or propagation of cardiac action potential that can generate arrhythmias, potentially fatal. In the last few years, the genetic studies are performed with next generation sequencing (NGS), obtaining global genomic information. However, this strategy requires capillary electrophoresis data validations. In this study, we developed and optimized a Sanger sequencing workflow for SCN5A gene exons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Forensic Science International: Genetics Supplement Series
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
